GLGeovana Maciel Lima

Geovana Maciel Lima

*This is an algorithmically generated author record based on publicly available information.

Geovana Maciel Lima has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effectiveness of COVID-19 Vaccination in Geriatric Population: Sociodemographic and Clinical Vaccine Adherence Outcomes in A University Outpatient Clinic in Tocantins

    by Candida Verônica de Andrade Paz, Rafael Pereira Camargo, Lauri Paulo Malacarne Junior, Tássia Aimê Nascimento, Marcelo Vicente Munin Ferreira, Geovana Maciel Lima, Neslayne Louise Campiol, Tania Pereira da Silva, Diego Lorenzi Agnolin, Edilson Galeno de Sousa Junior, et al.

    Aims: The first confirmed case of SARS-CoV-2 in Brazil was registered in February 2020 in the State of São Paulo, and quickly spread throughout all 27 federative units in the country. Given the rapid global spread and high virus infectivity, with significant economic, humanitarian, and social impacts, it has become imperative to develop an efficient strategy to contain the spread of the disease. In this context, mass vaccination planning proved to be desirable and promising, aiming to reduce morbidity and mortality caused by the new coronavirus (SARS-CoV-2) and reduce hospitalizations resulting from the disease. Study Design: Descriptive quantitative cross-sectional epidemiological research with convenience sampling of patients treated at the geriatrics outpatient clinic of the University of Tocantins. Place and Duration of Study: Information was collected from 128 volunteer patients between August 2022 and July 2023. Methodology: Information was collected from 128 volunteer patients between August 2022 and July 2023. Results: Analyzing the distribution of cases and deaths by age group in Brazil, there was a higher incidence among adults, with 69.3% of deaths in people over 60 years of age, and 64% of these had at least one risk factor. Conclusion: Cases of pneumonia associated with COVID-19 were more likely to occur in older, male patients and with comorbidities, compared to milder cases. Following the guidelines of the World Health Organization (WHO), priority groups were established, including healthcare professionals due to high work exposure and elderly people due to their immunological vulnerability and prevalence of comorbidities.

  • Incidência de meningite no estado de Santa Catarina de 2010 a 2020

    by Eric Pasqualotto, Amanda Carolina Fonseca da Silva, Kevyn Felipe Mendes, Ricardo Do Nascimento Neves, Vítor Maurício Merlin Maschietto, Geovana Maciel Lima, Nádia Roberta De Souza Silva

    OBJETIVO: Avaliar a incidência e o perfil epidemiológico de meningite no estado de Santa Catarina (SC) entre 2010 a 2020, segundo a faixa etária, gênero, etiologia e evolução. MÉTODOS: Trata-se de um estudo transversal descritivo quantitativo sobre o perfil epidemiológico da meningite entre 2010-2020 em SC. Os dados referentes ao ano do primeiro sintoma, faixa etária, gênero, etiologias e evolução foram obtidos através do Departamento de Informática do Sistema Único de Saúde do Brasil, sendo apresentados na forma de frequências absolutas e relativas. RESULTADOS: Identificaram-se 8.473 casos de meningite, dos quais 61,6% em homens. A maior e a menor incidência foram em 2017 e 2020, respectivamente. Na prevalência por faixa etária, a maior taxa foi em indivíduos de 20-39 anos (22,96%). A etiologia mais prevalente foi viral (43,51%), enquanto a menos prevalente foi a meningite por Haemophilus influenzae. A evolução com alta foi maior entre as mulheres, assim como os óbitos por meningite. A faixa etária com maior taxa de alta e menor taxa de óbitos por meningite foi de 5 a 9 anos. Em relação à etiologia, a menor taxa de óbitos por meningite e a maior taxa de alta foram identificadas na meningite viral. CONCLUSÕES: Identificou-se a permanência da endemia de meningite em SC no período analisado, embora em 2020 houvera queda, o que pode estar associado à pandemia da COVID-19. Ademais, os óbitos por meningite reduziram em comparação à década anterior, representando 8,34% dos desfechos.

  • Open Access

    AVALIAÇÃO DO POTENCIAL TRIPANOCIDA DE DERIVADOS TIOSSEMICARBAZONAS: UMA REVISÃO

    by Daniel Lopes Araújo, José Eufrazino Júnior, Vinicius Santos Silva, Carla Franco Mendonça de Araújo, Thaynara Hevellin Evangelista, Hilary Hevellin Evangelista, Geovana Maciel Lima, Ana Karoline Maciel Lima, Willian Moreira, Antônio Antunes Neto, et al.

    Neglected diseases are a group of communicable diseases that mainly affect tropical regions in developing countries. Among this group of diseases is Chagas disease, which has been classified among the six most important parasitic diseases in the world, and it is estimated that more than one billion people are at risk in countries that are considered endemic. The aim of this study is to conduct a literature review on the trypanocidal activity of thiosemicarbazone derivatives. The study is a review research that used 31 articles to highlight the scientific findings on the trypanocidal activity of the derivatives in question. Articles were included in the time estimate between 2010 - 2021 (last 12 years). The search and selection of the reference studies was performed in Scielo, Science Direct, PubMed and Google Academic databases. The literature highlights that thiosemicarbazones are considered privileged compounds with a wide scientific interest due to their diverse chemical and biological properties, such as: antitumor, antibacterial, antiviral, antiprotozoal, and anti-chagasic. The studies presented here, which demonstrate the investigations of compounds of this class and their derivatives, are an important step towards the conception of therapeutic methods against Trypanosoma cruzi. New studies are necessary to elucidate in an even more specific way the effects of these derivatives in vivo, in order to obtain an alternative pharmacological therapy for Chagas disease.

  • Open Access

    Evaluation of the anti-Leishmania mechanisms of Annona glabra L. (Annonaceae): A brief review

    by Daniel Lopes Araújo, Célio Pereira de Sousa Júnior, Maria Carolina Oliveira Silva, Vinicius Santos Silva, Samanta de Abreu Gonçalves, Geovana Maciel Lima, Thaynara Hevellin Evangelista, Hilary Hevellin Evangelista, Emanuel Osvaldo de Sousa, Antônio Antunes Neto, et al.

    Leishmaniasis is a neglected tropical disease caused by protozoan parasites of the genus Leishmania and characterized by the formation of skin ulcers. Despite the large number of cases, reaching worldwide proportions, there are many factors to be discussed regarding the treatment of the disease, which although much discussed, is still poorly elucidated. The objective of this review study is to identify the main anti-Leishmania mechanisms of Annona glabra L. (Annonaceae). This is a literature review study. To this end, we used the following descriptors in the search: natural products, leishmaniasis, mechanism of action and Leishmania (together and separately). In the selection criteria we opted for full articles, in the period 2012 - 2021 (last 10 years), in Portuguese and English. The searches were performed in the following databases: Scientific Electronic Library Online (SciELO), Latin American and Caribbean Literature on Health Sciences (LILACS) and Google Scholar. The articles were selected first by title, then by abstract, and finally by complete reading. The potential of natural products and their use in traditional medicine for the treatment of diseases makes them the target of research for new drugs. Different Annona species have demonstrated antileishmanial activity when evaluated in vitro. The substances that show leishmanicidal activity in Annona glabra extract are the alkaloids. New studies can be developed to elucidate even more specifically the effects of this natural product in vivo, in an attempt to obtain a new pharmacological alternative for the treatment of leishmaniasis.